top of page

Biotheryx's CEO on the company's protein degradation platform and CDK4/6 program that is IND cleared and will be entering the clinic

  • May 16, 2024
  • 1 min read

Leah Fung describes how Biotheryx is leveraging the E3 ligase Cereblon to enable its protein degradation, and discusses the lead CD4/6 program that recently had an IND cleared and others in the pipeline.



Join the BiotechTV mailing list

Thanks for subscribing!

Follow BiotechTV

  • Twitter
  • LinkedIn
  • Facebook
  • TikTok
  • Instagram

Also look for unique social pages for BiotechTV U.

Sponsor Spotlight

10x_Genomics_logo.svg.png

10x Genomics delivers powerful, reliable tools that fuel scientific discoveries and drive exponential progress to master biology to advance human health. Cited in more than 10,000 research papers, our innovative single cell, spatial, and in situ technologies enable discoveries across oncology, immunology, neuroscience, and more.

 

Our talented, dedicated science professionals have a distinguished record of creating innovative instruments, reagents, and software that analyze biological systems at a resolution that matches the complexity of biology.

bottom of page